Variation in use of imaging tests in newly diagnosed heart failure

Variation in use of imaging tests in newly diagnosed heart failure

(HealthDay)—Cardiovascular testing in patients with newly diagnosed heart failure (HF) varies among U.S. hospitals, according to research published online June 18 in the Journal of the American College of Cardiology: Cardiovascular Imaging.

Steven A. Farmer, M.D., Ph.D., of Northwestern University in Chicago, and colleagues examined the use of cardiovascular testing in the first six months following hospitalization for incident HF for 4,650 patients (79.1 percent) in the Cardiovascular Research Network (CVRN) Heart Failure study.

The researchers found that the majority of cardiovascular testing occurred during the incident HF hospitalization. Among patients who underwent testing, 4,345 (93.4 percent) had systolic function assessment, 4,085 (87.9 percent) had an echocardiogram, and 1,714 (36.9 percent) had coronary artery assessment. Testing rates varied widely across hospitals for both individual testing modalities (e.g., echocardiography, left heart catheterization, nuclear stress testing, and stress echocardiography) and specific clinical indications (e.g., disease assessment and systolic function assessment).

"For with newly diagnosed HF, we did not observe widespread overuse of cardiovascular testing in the six months following incident HF hospitalization relative to existing HF guidelines," the authors write. "Variations in testing were greatest for assessment of ischemia, in which testing guidelines are less certain."

One of the authors disclosed financial ties to a pharmaceutical company.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

More variation in costs than outcomes of PCI in VA system

Jan 23, 2015

(HealthDay)—For patients undergoing percutaneous coronary intervention (PCI) in the Veterans Affairs (VA) system, the variation in one-year risk-adjusted mortality is smaller than variation in risk-standardized ...

Revolutionary device found to lower blood pressure

Jan 22, 2015

A revolutionary device has been shown to significantly lower blood pressure among patients with uncontrolled high blood pressure, compared to those treated with usual drug measures - according to research from Queen Mary ...

Metabolic syndrome may raise death risk postangiography

Jan 22, 2015

(HealthDay)—For postangiography patients, metabolic syndrome is associated with increased mortality, especially in patients with stable angina, according to a study published in the Feb. 1 issue of The Am ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.